Indraprastha Medical Corporation Ltd Stock Analysis

BSE: 532150 | NSE: INDRAMEDCO | Hospital & Healthcare Services | Small Cap

BSE Share Price 01-Dec-2022 18:01
84.50 1.40 (1.68%)

DeciZen - Make an Informed Decision on Indraprastha Medical

Overall Rating

1. Quality

2. Valuation


3. Price Trend

Semi Strong

Indraprastha Medical Price Chart

P/E Ratio (SA) :
Market Cap :
774.6 Cr.
52-wk low :
52-wk high :
Bole Toh?

1. Is Indraprastha Medical Corporation Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Indraprastha Medical Corporation Ltd is a good quality company.

2. Is Indraprastha Medical Corporation Ltd undervalued or overvalued?

The key valuation ratios of Indraprastha Medical Corporation Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Indraprastha Medical Corporation Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Indraprastha Medical Corporation Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Indraprastha Medical:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Indraprastha Medical Corporation Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

ROCE % 14.8%17.1%15.4%11.6%11.2%9.5%12.2%18.1%1.9%21.8%-
Value Creation Index

Growth Parameters

Growth Parameters Colour Code Guide

Sales 6076787147557667537888316138881,000
YoY Gr. Rt. %-11.7%5.4%5.7%1.4%-1.7%4.7%5.4%-26.2%44.8%-
YoY Gr. Rt. %-23.6%-8.5%-22.8%6.2%-17.2%33.2%50.8%-93.6%2106.5%-
BVPS (₹) 18.720.421.324.425.225.326.629.229.835.537.5
Adj Net Profit 28.735.632.525.126.622.129.444.32.862.777
Cash Flow from Ops. 66.958.164.362.327.647.775.286.526.871.3-
Debt/CF from Ops.


CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 4.3%3%4.1%44.8%
Adj EPS 9%18.6%28.7%2106.5%
Share Price 8.4% 10.2% 27.8% -0.7%

Key Financial Parameters

Performance Ratio Colour Code Guide

Return on Equity % 17.419.9171211.79.512.417.31.12122.9
Op. Profit Mgn % 1313.411.910.610.49.910.410.56.713.513.9
Net Profit Mgn %
Debt to Equity
Working Cap Days 7776757273695953714895
Cash Conv. Cycle 10-4-6-51-3-13-15-1633

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 22.90%

Net Profit is growing at healthy rate in last 3 years 28.68%

Sales growth is good in last 4 quarters at 23.06%

Sales growth has been subdued in last 3 years 4.06%

Latest Financials - Indraprastha Medical Corporation Ltd.

Standalone Consolidated
TTM EPS (₹) 8.4 -
TTM Sales (₹ Cr.) 1,000 -
BVPS (₹.) 37.5 -
Reserves (₹ Cr.) 252 -
P/BV 2.25 -
PE 10.12 -
From the Market
52 Week Low / High (₹) 52.00 / 93.05
All Time Low / High (₹) 4.00 / 102.55
Market Cap (₹ Cr.) 775
Equity (₹ Cr.) 91.7
Face Value (₹) 10
Industry PE 65.1

Management X-Ray of Indraprastha Medical :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Indraprastha Medical

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)


Indraprastha Medical Corporation Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Indraprastha Medical on 01-Dec-2022 18:01 is : 84.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Dec-2022 18:01 the market cap of Indraprastha Medical stood at ₹ 774.6.
The latest PE ratio of Indraprastha Medical as of 01-Dec-2022 18:01 is 10.12.
The latest PB ratio of Indraprastha Medical as of 01-Dec-2022 18:01 is 2.25
The 52-week high of Indraprastha Medical is ₹ 93.05 and the 52-week low is ₹ 52.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Indraprastha Medical is ₹ 1,000 ( Cr.) .

About Indraprastha Medical Corporation Ltd

Indraprastha Medical Corporation (Indraprastha) was incorporated as public limited company on  March 16,1988 with the ROC and obtained the certificate of commencement of business on April 7,1988.It is a Delhi-based healthcare company which operates through Indraprastha Apollo Hospital. Indraprastha Apollo, a 695 bed specialty hospital, was commissioned on December 1995 in collaboration with New Delhi administration. The hospital, spread across an area of 675,000 sq ft, is the largest corporate hospital in India and the fourth largest in the world. The hospital has various centres such as Apollo cardiac center, Apollo cancer center and Apollo surgical science center, among others. The company has operated on around 7.4 million patients. The group also owns 12 hospitals and four clinics. It is running a multi super-specialty hospital.

Business area of the company :

It offers a range of diagnostic, medical, and surgical facilities for the care of its patients. The company provides treatments in the areas of anaesthesiology, oncology, cardiology, neurology, orthopedics, nephrology, ophthalmology, nuclear medicine, pediatrics, physiotherapy and rehabilitation, psychiatry and psychology, radiology, urology and andrology, gastroenterology, gynecology and obstetrics, dermatology, dietetics and nutrition, and respiratory and sleep medicine. It also offers various surgical services, including dental, cardiothoracic, neuro, vascular, joint, plastic and cosmetic, and general surgeries. In addition, the company’s diagnostic services include lab services, radio-diagnosis, nuclear medicine, endoscopy lab, bronchoscopy lab, and blood bank. Further, it offers ambulance and air ambulance services, as well as out patient consultation services.

As of March 31, 2009, Indraprastha Apollo Hospitals performed around 2000 cardiac surgeries, 400 joint replacements, 1000 onco surgeries, 90 liver transplants and 135 renal transplants. The company's hospitals are located in Chennai, Hyderabad, Kolkata, Ahmedabad, Bangalore, Bilaspur and Madurai.


  • 1988- The company was incorporated as public limited company on 16th March with the ROC and obtained the certificate of commencement of business on 7th of April. The hospital has 4 cardio-thoracic surgery operation theatres (OTs), 2 neurosurgery OTs, 5 major OTs, 4 minor OTs, 2 emergency OTs and 1 maternity OT.  These OTs are being used for the various specialties/services that are available in the hospital. 
  • 1990 -The company entered into an agreement with Indian Hospital Corporation on 17th July. IHCL is providing technical consultancy and project consultancy for setting up, commissioning and functioning of the hospital. The Company has also installed 2 DG sets of 750 KVA capacity each as standby arrangements. Three steam boilers with a capacity of 2000 kg/hr each with requisite storage and distribution systems have been installed to meet the requirement of steam. 
  • 1992 -The company entered into an agreement with MCS for redressal of investor grievances for a period of six months from the last date of dispatch of letter of allotment advice/share certificates/refund orders. 
  • 1996 - The Cardiology and Cardiothoracic Surgery have state-of-the-art facilities for cardiac care and treatment.  3 Catheterization laboratories with Digital imaging & electrophysiology facilities have been set-up. The Neuro Sciences department is one of the few centres in Asia providing advanced neuro surgery facilities. Since August, 300 beds have been commissioned with an average occupancy of 200 beds. The Company is setting up Indraprastha Apollo Hospitals a 695 bed multi-disciplinary super specialty tertiary care hospital with state of the art facilities at a site on Delhi-Mathura Road, near Sarita Vihar, New Delhi. The Company proposes to set-up satellite centres in strategic locations in and around Delhi which will have 8-10 consultancy rooms and basic diagnostic facilities. An Incinerator with a capacity of 125 kgs per hour has been installed for disposal of combustible waste, infectious waste, human tissue, bandage, dressing linen etc. IMCL has installed compressors for compressed air and medical gases. The company has entered into an equipment lease agreement with IHCL for leasing of specified medical equipment.
  • 1997- Indraprastha Medical Corporation entered the capital market with a public issue of 2,29,18,900 equity shares of Rs.10 each for cash at par aggregating to Rs.22,91,83,000. Indraprastha Medical Corporation is a multi-speciality 600-bed corporate hospital being set up in New Delhi. Besides the hospital complex the corporate hospital also has plans to set up five satellite centres. The first joint sector venture in healthcare in the country was set up in collaboration with NCT (National Capital Territory) of Delhi, bringing together the strategic focus and operational advantages of the private sector. 
  • 1998 - Recently, a combined team of cardiologists and neurologists successfully developed a new technique of safely embolizing septal artery without affecting vital circulation of the rest of the heart muscle.  The hardware was a combination of material used in coronary angioplasty and cerebral AVM repairs.  This procedure has been performed for the first time in the world. A new technique thrombolysis devised by the neuroradiology unit to treat early stroke victims involves injection of a special medicine directly into the clot within an artery in the brain to dissolve it. Palliative Medicine, for the first time in the country, being offered as a dedicated speciality service by the hospital, is a concept of medical care that provides for people who are terminally ill. The Assisted Reproductive Unit comprising a team of highly skilled and experienced specialists trained in the UK and USA has been commissioned. Eight national and international conferences held with renowned faculty drawn from across ten countries, most important of them being OPTIMA 98 - a 3-day international conference conducted by the Department of Neurosciences, being the first of its kind in the country. A six-month certificate course on Operation Theatre Technology and Tertiary Nursing Care for qualified registered nurses graduated from various institutions commences 1 July, comprising two semesters each of clinical and theoretical practice. The hospital is one of the multicenteric multinational drug trial centres for drug control studies for hypertension. The hospital is now on the internet with the most comprehensive website with, inter alia, an animated walkthru of the hospital, facility for online appointments and updates on all available services. 
  • 1999- The group also has an ambitious plan of setting up hospitals in Ludhiana, Lucknow, Ahmedabad, Vizag and possibly Calcutta and Mumbai. Abroad, after Dubai and Muscat, the company is looking at East Africa and Sri Lanka and Bangladesh. The Apollo Hospitals group has no immediate plans to include its Delhi-based associate company -- Indraprastha Medical Corporation (IMCL) -- in the on-going consolidation process involving merger of the remanning three group companies into single entity. Besides the Delhi Government, IMCL has been promoted by Dr. Reddy and Shrodders Ventures of the UK who together hold 49 per cent stake in the company.  The public holds a 25 per cent stake in IMCL. The agreement entered into between the promoters in 1998 gives an option to the Delhi Government to divest its 26 per cent stake in IMCL in three tranches once the Indraprastha Apollo Hospital becomes fully operational.  The stake has to be divested at a pre-determined compounded rate or the prevailing market price, whichever is higher. 2005 Delist from The Delhi Stock Exchange Association Limited w.e.f. January 20, 2005.

Future Plans

Indraprastha Medical Corporation plans to set up more than ten satellite clinics in and around Delhi to facilitate easy availability of Apollo-type medical services to a larger cross-section of society. These clinics are to take the shape of mini-hospitals with all basic back-up emergency services mainly aimed at providing post-treatment facilities to Apollo Hospitals patients. Each clinic would cost between Rs 10 to Rs 15 million. It also plans to acquire some of the existing small clinics situated at various locations, upgrade them and start as Apollo clinics.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now